24 July 2026

Introducing: Pneumococcal 21-valent conjugate vaccine

1 minute read

Geriatrician, A/Prof Michael Woodward AM introduces a 21-valent pneumococcal conjugate vaccine.

In this Product Explainer:

Geriatrician, A/Prof Michael Woodward AM introduces a 21-valent pneumococcal conjugate vaccine and discusses implementation considerations for GPs and healthcare immunisers (5 mins).

This video is sponsored by Merck Sharp and Dohme (Australia) Pty Ltd

End of content

No more pages to load

Register for a new account

Email Address

Password

Confirm Password

First Name

Last Name

Full Name LEAVE THIS BLANK

What field do you work in?

Type of University work:

Industry Specialty:

Other:

Billing Address

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

I agree to the Terms and conditions and privacy policy *

Processing...

Introducing: Pneumococcal 21-valent conjugate vaccine

Relentless disadvantage

Prac payment expansion receives mixed reviews

Discrimination-related AHPRA notifications more likely to be closed without action

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Log in

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover